Malvern Instruments opens new multipurpose facility in Houston

Malvern, UK: On 19 March 2012, and just one week after moving in, materials characterization company Malvern Instruments has officially opened a new multipurpose facility in Houston, Texas. At 22,000 sq. ft. the new building is double the size of Malvern’s previous premises in Houston and houses state-of-the-art laboratories, product development, manufacturing and commercial operations. [...]

QUANTUMDx GROUP AND A*STAR INSTITUTE OF MICROELECTRONICS TO BRING NANOWIRE BASED DNA SEQUENCING TO MARKET

A*STAR Institute of Microelectronics (IME), has signed a research collaboration agreement with QuantuMDx Group (QMDx), a UK based biotech company which is developing a range of portable technologies for diagnostics, DNA sequencing and proteomics. Under this collaboration, IME will further advance QMDx’s DNA sequencing nanowire biosensor to the point of commercialization. QMDx is pioneering a [...]

Roche extends tender offer for Illumina

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN), at a price of $44.50 per share, to 6:00 p.m., New York City time, on April 20, 2012. The tender offer was previously scheduled to expire at 6:00 p.m., [...]

Transparent Corporation of Japan, and Molecular Response Sign Key Collaboration and Supply Agreement to Launch Novel Ex-Vivo 3D Cell Culture System Focused on Oncology Applications

Transparent Inc., a leader in 3D cell culture plate design and applications supported by comprehensive patent portfolio in biomaterial sciences, and Molecular Response Laboratories (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, today announced extension of their original validation studies and execution [...]

Illumina Comments on Second Extension of Roche’s Unsolicited Tender Offer

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today issued the following statement regarding Roche’s decision to extend for the second time its unsolicited tender offer to acquire all outstanding shares of Illumina for $44.50 [...]

Chugai Pharmaceutical Extends Multi-Year Licensing of Genedata Expressionist

Basel (Switz) and Tokyo (Japan)-- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Chugai Pharmaceutical Company extended its multi-year licensing agreement of Genedata Expressionist® software. One of Japan's leading pharmaceutical companies and a member of the Roche Group, Chugai develops therapeutic drugs in the fields [...]

Agilent Technologies Target-Enrichment for Next-Generation Sequencers Now Runs Four Times Faster

Agilent Technologies Inc. (NYSE: A) today introduced a much faster version of the HaloPlex target enrichment system for desktop sequencers. The protocol that previously required approximately 24 hours can now be run in less than six. This enables users to go from sample prep to sequencing in less than a work shift. "Recently we had [...]

Life Technologies’ benchtop Ion Proton Sequencer makes Arablab debut

The Ion Proton featured heavily at the Consumer Electronics Show in Las Vegas and the World Economic Forum in Davos. Subject to regulatory approvals beyond research use only, the technology may one day guide patients, particularly those with cancer - to receive treatment most likely to work with their individual genetic profile. The low cost [...]

Horizon to provide genetically defined human genomic reference standards for cancer diagnostics proficiency testing schemes

Cambridge, UK,: Horizon Diagnostics (HDx), a division of Horizon Discovery Limited, a leading provider of research tools to support the development and prescription of personalized medicines, today announced it has signed a strategic partnership agreement with the European Molecular Genetics Quality Network (EMQN). Under the terms of the agreement, HDx will provide genetically defined human [...]

Smiths Detection Wins €100m Doha Airport Order

London, UK, - Smiths Detection, part of global technology business Smiths Group, has won a contract worth more than €100 million to supply all the main security scanning systems at the New Doha International Airport (NDIA) in Qatar. The prestigious order to equip one of the world’s most advanced airports includes a range of automatic [...]

Access IBO on Knowledge Center